Please assess the completion status of the following clinical trial:

Trial Title: RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* creatinine clearance rates ≤60 mL/min using the Cockcroft-Gault formula~* Patients who undergo coronary catheterization~* Age of 19 or over 19.~Exclusion Criteria:~* pregnancy~* lactation~* having received contrast media within 7 days of study entry~* emergent coronary angiography~* acute renal failure~* end-stage renal disease requiring dialysis~* history of hypersensitivity reaction to contrast media~* cardiogenic shock~* pulmonary edema~* multiple myeloma~* mechanical ventilation~* parenteral use of diuretics~* use of N-acetylcysteine~* use of metformin or nonsteroidal anti-inflammatory drugs within 48 hours of the procedure.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).